Baxter Buys Urine Monitoring Co FlowSense for $9.5m

FlowSense
by Globes correspondent (September 10, 2013)

FlowSense’s URINFO fluid monitoring system provides accurate, real-time, and continuous monitoring of urine output.

The Trendlines Group has announced the acquisition of portfolio company Flowsense Medical Ltd. by global healthcare company Baxter International (NYSE: BAX). FlowSense’s URINFO fluid monitoring system provides accurate, real-time, and continuous monitoring of urine output. The company was founded by Trendlines in 2009 and taken public on the Tel Aviv Stock Exchange the following year.

Prior to founding FlowSense, Trendlines acquired the assets upon which the company was established and created a new company to develop and market the company’s products. The company has since sold its products in Europe, the US, Israel, and China. FlowSense generated interest from several potential strategic partners prior to the acquisition by Baxter for $9.5 million, including liabilities

Read the full article on Globes.

News about the FlowSense acquisition appeared in other media.

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+

  • Tags